HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 7 March 2011

Recent cost utility studies

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 8  papers were listed this time. Here's a handful:

Lee WC, Conner C, Hammer M. Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US. Curr Med Res Opin. 2011 Feb 25. [Epub ahead of print] PubMed PMID: 21348806.

Kamae MS, Kamae I, Cohen JT, Neumann PJ. Regression analysis on the variation in efficiency frontiers for prevention stage of HIV/AIDS. J Med Econ. 2011 Feb 18. [Epub ahead of print] PubMed PMID: 21332273.

Eckard N, Janzon M, Levin LA. Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies. Scand Cardiovasc J. 2011 Feb 17. [Epub ahead of print] PubMed PMID: 21329415.

Beckwith J, Nyman JA, Flanagan B, et al. A health economic analysis of clinical islet transplantation. Clin Transplant. 2011 Feb 16. [Epub ahead of print] PubMed PMID: 21323736.